fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Experimental gene therapy reverses sickle cell disease for years

Written by | 24 Dec 2021

A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most… read more.

Statin use affects prostate cancer screening results

Written by | 10 Dec 2021

Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did… read more.

Aspaveli receives positive CHMP opinion for treatment of paroxysmal nocturnal haemoglobinuria – SOBI + Apellis Pharma

Written by | 9 Dec 2021

Swedish Orphan Biovitrum AB (publ) (Sobi) and Apellis Pharmaceuticals, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted… read more.

Researchers find warning signs for dementia in the blood

Written by | 24 Oct 2021

Certain microRNAs indicate risk for cognitive decline DZNE – German Center for Neurodegenerative Diseases Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules… read more.

New discovery explains antihypertensive properties of green and black tea

Written by | 13 Aug 2021

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the… read more.

New Data for Genentech’s Hemlibra reinforce safety profile in people with hemophilia A

Written by | 1 Aug 2021

Genentech, a member of the Roche Group announced results from the final analysis of the Phase IIIb STASEY study , which confirm the favorable safety profile of Hemlibra… read more.

Impact of blood pressure control programs at barbershops nationwide

Written by | 29 Jun 2021

Hypertension, or high blood pressure, kills more Americans than any other health condition. It is especially prevalent in Black Americans and is exacerbated by structural barriers to accessing… read more.

Cannabis reduces blood pressure in older adults

Written by | 12 Feb 2021

A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in… read more.

Elocta gains increased access for people with haemophilia A in the UK.- SOBI

Written by | 27 Jun 2020

Through an agreement with National Health Service (NHS) and Sobi,( Swedish Orphan Biovitrium) people living with haemophilia A in the United Kingdom will have increased access to Elocta… read more.

Novartis announces data showing Jakavi (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease.

Written by | 23 Apr 2020

Data from the Phase III REACH2 study published in The New England Journal of Medicine show Jakavi (ruxolitinib) improves outcomes across a range of efficacy measures in patients… read more.

Novartis announces data showing Jakavi (ruxolitinib) more effective than best available therapy in acute graft-versus-host disease.

Written by | 23 Apr 2020

Data from the Phase III REACH2 study published in The New England Journal of Medicine show Jakavi (ruxolitinib) improves outcomes across a range of efficacy measures in patients… read more.

Highlights from IMW 2019

Written by | 8 Nov 2019

Many of the 4,000 delegates at IMW in Boston this year, such as Professor Mohamad Mohty (Paris, France) highlighted the spirit of collaboration, with locals Professor Paul Richardson and Professor Noopur Raje discussing their highlights… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.